52.73 USD
-1.1 (-2.04%)
52.73 USD
0 (0%)
Taking everything into account, PCVX scores 3 out of 10 in our fundamental rating. PCVX was compared to 525 industry peers in the Biotechnology industry. PCVX has a great financial health rating, but its profitability evaluates not so good. PCVX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year PCVX has reported negative net income.
- PCVX had a negative operating cash flow in the past year.
- In the past 5 years PCVX always reported negative net income.
- In the past 5 years PCVX always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -20.72%, PCVX is in the better half of the industry, outperforming 75.81% of the companies in the same industry.
- Looking at the Return On Equity, with a value of -22.72%, PCVX belongs to the top of the industry, outperforming 81.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.72% | ||
| ROE | -22.72% | ||
| ROIC | N/A |
ROA(3y)-21.33%
ROA(5y)-23.51%
ROE(3y)-23.3%
ROE(5y)-26.19%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PCVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, PCVX has more shares outstanding
- PCVX has more shares outstanding than it did 5 years ago.
- PCVX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- PCVX has an Altman-Z score of 14.08. This indicates that PCVX is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 14.08, PCVX belongs to the top of the industry, outperforming 85.14% of the companies in the same industry.
- There is no outstanding debt for PCVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 14.08 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- PCVX has a Current Ratio of 8.83. This indicates that PCVX is financially healthy and has no problem in meeting its short term obligations.
- PCVX has a Current ratio of 8.83. This is in the better half of the industry: PCVX outperforms 77.90% of its industry peers.
- PCVX has a Quick Ratio of 8.83. This indicates that PCVX is financially healthy and has no problem in meeting its short term obligations.
- PCVX has a Quick ratio of 8.83. This is in the better half of the industry: PCVX outperforms 77.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.83 | ||
| Quick Ratio | 8.83 |
3. Growth
3.1 Past
- The earnings per share for PCVX have decreased by -5.09% in the last year.
EPS 1Y (TTM)-5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 4.14% on average over the next years.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-48.17%
EPS Next 2Y-28.35%
EPS Next 3Y-21.11%
EPS Next 5Y4.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- PCVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year PCVX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- PCVX's earnings are expected to decrease with -21.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-28.35%
EPS Next 3Y-21.11%
5. Dividend
5.1 Amount
- PCVX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VAXCYTE INC / PCVX FAQ
Can you provide the ChartMill fundamental rating for VAXCYTE INC?
ChartMill assigns a fundamental rating of 3 / 10 to PCVX.
What is the valuation status for PCVX stock?
ChartMill assigns a valuation rating of 0 / 10 to VAXCYTE INC (PCVX). This can be considered as Overvalued.
Can you provide the profitability details for VAXCYTE INC?
VAXCYTE INC (PCVX) has a profitability rating of 1 / 10.
Can you provide the financial health for PCVX stock?
The financial health rating of VAXCYTE INC (PCVX) is 8 / 10.
What is the expected EPS growth for VAXCYTE INC (PCVX) stock?
The Earnings per Share (EPS) of VAXCYTE INC (PCVX) is expected to decline by -48.17% in the next year.